PetMed Express Elects New Directors

Ticker: PETS · Form: 8-K · Filed: 2024-06-24T00:00:00.000Z

Sentiment: neutral

Topics: board-of-directors, governance

Related Tickers: PETS

TL;DR

PetMed Express adds two new board members, Bingle and Briscoe, effective June 24, 2024.

AI Summary

PetMed Express, Inc. announced on June 24, 2024, a change in its board of directors. Specifically, the company elected two new directors, Michael J. Bingle and Robert L. Briscoe, to serve until the 2026 annual meeting of stockholders. This follows the resignation of director Michael J. Shribman.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, potentially impacting future performance and shareholder value.

Risk Assessment

Risk Level: low — The filing concerns routine board changes and does not involve significant financial transactions or operational disruptions.

Key Players & Entities

FAQ

Who were the newly elected directors at PetMed Express?

Michael J. Bingle and Robert L. Briscoe were elected as new directors.

When were the new directors elected?

The new directors were elected on June 24, 2024.

Until when will the newly elected directors serve?

They will serve until the 2026 annual meeting of stockholders.

Who resigned from the board of directors?

Michael J. Shribman resigned from the board of directors.

What is the principal executive office address for PetMed Express?

The principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.

From the Filing

0001040130-24-000048.txt : 20240624 0001040130-24-000048.hdr.sgml : 20240624 20240624080939 ACCESSION NUMBER: 0001040130-24-000048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240624 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 241062155 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240624.htm 8-K pets-20240624 0001040130 FALSE 0001040130 2024-06-24 2024-06-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  June 24, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Director On June 20, 2024, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Leah A. Solivan to serve as a director of the Company beginning June 24, 2024. Ms. Solivan will hold this position until the 2024 annual meeting of the Company’s shareholders or until her successor is elected and qualified, subject to her earlier resignation or removal. Ms. Solivan will also serve on the Board’s Compensation and Human Capital Committee and Corporate Governance

View on Read The Filing